AR015513A1 - Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf - Google Patents

Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf

Info

Publication number
AR015513A1
AR015513A1 ARP990100476A ARP990100476A AR015513A1 AR 015513 A1 AR015513 A1 AR 015513A1 AR P990100476 A ARP990100476 A AR P990100476A AR P990100476 A ARP990100476 A AR P990100476A AR 015513 A1 AR015513 A1 AR 015513A1
Authority
AR
Argentina
Prior art keywords
tace
compound
polypeptide
identifying
tnf
Prior art date
Application number
ARP990100476A
Other languages
English (en)
Original Assignee
Wyeth Corp
Inmunex Corp
Maz Planck Inst For Biochemistry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp, Inmunex Corp, Maz Planck Inst For Biochemistry filed Critical Wyeth Corp
Publication of AR015513A1 publication Critical patent/AR015513A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se revela un método para identificar un compuesto que se asocia con la enzima conversora de alfa-TNF (TACE). Un polipéptido de la enzima conversora dealfa-TNF se produce en forma cristalina en una unica composicion. El polipéptido preferentemente comprende el dominio catalítico de la TACE. También puedecomprender los dominios pro y catalíticos de la TACE. El polipéptido puede ser codificado por los residuos de aminoácidos 1-477 de la TACE, puede tambiénincluir cambios simples de aminoácidos y secuencias fusionadas adicionales de Gly-Ser(His)6 en el C terminal. Un socio en la union durante la co-cristalizacioncon el polipéptido de TACE puede incluirse en la composicion. El Cristal en la composicion tiene preferentemente una estructura cristalina que difracta a 2.0Angstrom. Las coordenadas de difraccion por rayos X de la estructura cristalina también se revelan. El compuesto se designa de acuerdo a estas coordenadas demanera que forme un enlace con TACE. El compuesto es subsecuentementesintetizado y se determina su capacidad de asociacion con TACE.
ARP990100476A 1998-02-04 1999-02-04 Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf AR015513A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7370998P 1998-02-04 1998-02-04
US5008398A 1998-03-30 1998-03-30
US11747699P 1999-01-27 1999-01-27

Publications (1)

Publication Number Publication Date
AR015513A1 true AR015513A1 (es) 2001-05-02

Family

ID=27367666

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990100476A AR015513A1 (es) 1998-02-04 1999-02-04 Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf
ARP000103727A AR024804A1 (es) 1998-02-04 2000-07-19 Un medio de lectura en computadora que tiene grabado datos de coordenadas cristalograficas de rx de una enzima conversora de a-tnf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP000103727A AR024804A1 (es) 1998-02-04 2000-07-19 Un medio de lectura en computadora que tiene grabado datos de coordenadas cristalograficas de rx de una enzima conversora de a-tnf.

Country Status (15)

Country Link
EP (1) EP1053304B1 (es)
JP (1) JP2004503202A (es)
CN (1) CN1342200A (es)
AR (2) AR015513A1 (es)
AT (1) ATE366303T1 (es)
AU (1) AU2574099A (es)
CA (1) CA2319040A1 (es)
DE (1) DE69936445T2 (es)
DK (1) DK1053304T3 (es)
ES (1) ES2293718T3 (es)
HU (1) HUP0101596A1 (es)
IL (3) IL137557A0 (es)
NO (1) NO20003687L (es)
NZ (1) NZ505959A (es)
WO (1) WO1999040182A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406901B1 (en) 1995-06-08 2002-06-18 Immunex Corporation TNF-a converting enzyme
US20030018166A1 (en) * 2000-08-03 2003-01-23 Sacchettini James C. Structure of isocitrate lyase enzyme from mycobacterium tuberculosis and inhibitory agents to combat persistent infection
US7138264B1 (en) 2002-05-24 2006-11-21 Schering Corporation Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
US20060035301A1 (en) * 2004-01-26 2006-02-16 University Of Massachusetts Method of identifying protein kinase modulators and uses therefore
CN104667257B (zh) * 2013-11-27 2017-09-12 财团法人工业技术研究院 应用生发胜肽的方法及医药组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5702935A (en) * 1994-04-28 1997-12-30 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method and compounds for inhibiting lipid biosynthesis of bacteria and plants
DK0830130T3 (da) * 1995-06-08 2004-12-20 Immunex Corp TNF-alfa-omdannende enzym
CA2226963A1 (en) * 1995-08-30 1997-03-06 Xiaode Lu Crystalline zap family proteins
WO1997015588A1 (en) * 1995-10-26 1997-05-01 St. Jude Children's Research Hospital Protective protein/cathepsin a and precursor: crystallization, x-ray diffraction, three-dimensional structure determination and rational drug design
CA2249985A1 (en) * 1996-03-26 1997-10-02 Glaxo Group Limited Tumour necrosis factor alpha convertase

Also Published As

Publication number Publication date
JP2004503202A (ja) 2004-02-05
IL163513A0 (en) 2005-12-18
NO20003687D0 (no) 2000-07-18
HUP0101596A1 (hu) 2001-08-28
AU2574099A (en) 1999-08-23
CN1342200A (zh) 2002-03-27
ES2293718T3 (es) 2008-03-16
DE69936445T2 (de) 2008-04-10
AR024804A1 (es) 2002-10-23
DE69936445D1 (de) 2007-08-16
ATE366303T1 (de) 2007-07-15
EP1053304A2 (en) 2000-11-22
EP1053304B1 (en) 2007-07-04
IL137557A0 (en) 2001-07-24
CA2319040A1 (en) 1999-08-12
DK1053304T3 (da) 2007-11-05
IL163513A (en) 2007-03-08
NZ505959A (en) 2003-05-30
WO1999040182A2 (en) 1999-08-12
NO20003687L (no) 2000-09-19
WO1999040182A3 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
ATE44533T1 (de) Hemmen von enzymen.
AR053946A2 (es) Variante de alfa-amilasa de bacillus stearothermophilus original
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
CY1112833T1 (el) Καινοφανης προσδετης της κυτοκινης ζcυτοr17
DE69434817D1 (de) Protease varianten
DK0502089T4 (da) Silicasoler, en fremgangsmåde til fremstilling af silicasoler og anvendelse af solerne
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
DK0765343T3 (da) Monoklonale antistoffer imod CD44v6
ATE169678T1 (de) Stabilisierte enzyme
DK39693D0 (da) Enzym
NO20001668D0 (no) Anvendelse av et DNA-fragment, samt komplementære kjeder, derivater og deler derav
DE59208300D1 (de) Verwendung von halogenkohlenwasserstoff-freien reinigungsmitteln zur fluxentfernung von elektronischen und elektrischen baugruppen
AR015513A1 (es) Metodo para identificar un compuesto que se asocia con la enzima conversora de alfa-tnf
ATE426028T1 (de) Zellvolumenregulierte humane kinase h-sgk
IL200132A0 (en) Method for cell adhesion and wound healing
EP0498784A3 (en) Inhibitors of retroviral protease
DK0458937T3 (da) Varianter af PAI-2
NO895002D0 (no) Enzymhemmende aminosyrederivater.
ATE170631T1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ATE374824T1 (de) Lösliche notch basierte substrate für gamma secretase, methoden, zusammensetzungen und verwendungen davon
DK0876610T3 (da) Fremgangsmåde og anvendelse af polypeptid i sædcelle-æg-binding til at foröge eller mindske fertilitet
ATE180679T1 (de) Neue verbesserungen hinsichtlich der radiomarkierung von proteinen
DE59811521D1 (de) Verfahren zur herstellung einer elektrode für entladungslampen
DE60125386D1 (de) Verfahren zur Prävention einer durch Gefrieren induzierten Abnahme der Aktivität eines Proteins

Legal Events

Date Code Title Description
FA Abandonment or withdrawal